- Report
- October 2024
- 191 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 189 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 142 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- October 2024
- 202 Pages
Global
From €2230EUR$2,450USD£1,912GBP
- Report
- April 2025
- 441 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 173 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 147 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- February 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- June 2024
- 211 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- November 2024
- 110 Pages
United States
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 150 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- January 2024
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2018
- 80 Pages
Global
From €3003EUR$3,300USD£2,575GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes.
The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments.
Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more